CONSENT FORM PACKET

 

 

Most investigators obtain consent through personal discussion.  This method is highly recommended, since it allows specific questions to be answered.  There are three practical reasons for a written consent form:

 

    A written consent form is usually required by regulatory agencies.

    The consent form can aid the investigator in discussing the study with

     the subject by providing a checklist of items.

    The consent form can help the subject to recall the discussion with

     the investigator.

 

Should a subject have difficulty recalling any aspect of the discussion, a clear and understandable form--left with the subject--may help resolve the confusion, refresh the memory, and encourage compliance.

 

Enclosed is a packet of information which we hope will help you prepare the consent form for your research study.  It contains:

 

               List of Required Elements of Informed Consent

               Required Elements of Informed Consent, with examples

               Example of Abbreviated Consent Form for Minimal Risk Studies

               Example of Consent Form for a Greater than Minimal Risk study.

 

It is acceptable for you to design a consent form in your own personal style so long as all of the required elements are included.  You must also include the "Patient Representative" statement if the subjects are hospital patients.

 

I will be glad to answer questions, provide clarification on requirements or definitions, or assist in preparing consent forms.  I encourage you to call on me for guidance in preparing consent forms for studies involving children and/or incompetent subjects; special considerations must be made.  Please feel free to call me at 651-254-3391.

 

 

 

 

Bobette K. Godding

Manager, Office of Research Subjects


LIST OF REQUIRED ELEMENTS OF INFORMED CONSENT

 

1.      An invitation to participate.

 

2.      A statement of the general purpose of the study.

 

3.      The procedures to be followed. Identify any procedures that are experimental.

 

4.      Discomforts and inconveniences.  This includes length of time involved, additional trips to the clinic which wouldn't be required for clinical purposes, etc.

 

5.      Risks.  Include risks which a person would want to know about; which this medical community would inform the patient; which are relatively frequent; which are relatively serious. Consider physical risks, but also legal, economic, and psychological risks.

 

6.      Benefits to the subject.

 

7.      Standard treatment to be withheld or alternative procedures that are available.

 

8.      Costs to the subject as a result of participation or compensation that may be offered to pay for expenses, time, inconvenience, but not as an inducement to assume risk.

 

9.      For studies involving greater than minimal risk include availability of treatment and/or compensation in the event of a research-related injury.

 

10.  Confidentiality.  If this is a study monitored by the FDA, include the possibility of FDA access to medical/study records.  Include any other agency, which could have access, e.g., State Health Department, sponsoring agency, pharmaceutical company.

 

11.  Offer to answer questions.  Include name and telephone number of investigator as well as the statement on the availability of the Patient Representative.

 

12.  Voluntary nature of participation.  Include that refusal to participate or withdrawal from the study will not affect the subject's relationship with REGIONS HOSPITAL or its staff.

 

13.  Statement that the subject will be given a copy of the consent form.  (May be unsigned.)

 

14.  Signature of research subject and person obtaining consent.

 

Additional Elements When Appropriate

a)        A statement that the treatment or procedure may involve risks to the subject (or embryo or fetus) which are currently unforeseeable.

b)        Anticipated circumstances under which the subjects participation maybe terminated without regard to the subject's consent.

c)        The consequences of a subject's decision to withdraw from the study, and procedures for the orderly termination of participation.

d)        A statement that significant new findings developed during the course of the study which may relate to the subject's willingness to continue participation will be provided.

e)        The approximate number of subjects in the study.

f)          Additional elements are required in research involving children, incompetent subjects, pregnant women, fetuses, prisoners, etc.  Please contact the IRB office at 651-254-3391 for help.

 

There Are Many Ways To Express Each Of These Elements.  A Good Consent Form Will Be Clear - Brief - Complete - Accurate - Fair

 


 

Required Elements of Informed Consent With Examples

It is strongly suggested that the consent forms be separated into sections, with boldface or capitalized headings.  This is particularly important when consent forms are long.

 

1.   Invitation To Participate:

 

Example:

You are invited to participate in a research study.

 

2.   Purpose/Introduction:  What is being studied?  Why?  Why you?  Who are the investigators?  This section should set the stage and provide a quick overview.

 

Examples:

     A study is being done by D. Jones, M.D. and R. Smith, Ph.D., to learn more about a cause of (condition), the disease you have.  You are invited to be in the study.

 

XX is currently the standard treatment for (disease). It is known that a percentage of people have not responded to XX.  Since you have not responded to XX, you are invited to be in a study of an experimental treatment for this disease.

 

3.   Procedures:  What, if anything, will happen to you if you participate?  How long will it take?  The explanation should not include procedures that are part of standard care.  Procedures that are different from or in addition to standard care must be included.  They should be described in terms of subject experience, e.g., blood drawing, rather than laboratory tests (CBC, etc.).  Procedures such as, randomization, or other procedures affecting a subject's time for contacting relatives, making arrangements for babysitting, transportation, should be included to help decrease non-compliance.

 

Examples:

If you agree to participate, you will return to the clinic for 10 additional monthly visits of one hour each.  At each visit you will have the following tests that are not for your treatment or diagnosis...

 

If you agree to participate you will be interviewed for one hour.  The questions will concern your background and how you feel about the treatment your family has received in the clinic.  The interview will take place in your home and, if you agree, it will be tape recorded.

 

If you agree to be in the study you will be randomly assigned to one of two groups.  This means you will have an equal chance of being in either group.  Neither your doctor nor you will make the decision.  The two groups are:

     A.  Group A will have the standard dosage for 6 weeks instead of the usual 3 weeks.

     B.  Group B will have the usual treatment time but at twice the usual dosage.

 

4&5  Risks/Discomforts/Inconveniences: 

Subjects should be able to gain a fair idea of the risks that they are taking and of the discomforts or inconveniences they might experience as a result of consenting.  These include not only physical risks, but also potential legal, economic, or psychological risks that are relevant.  A general rule of thumb is that any side effect that is "relatively" frequent or that is "relatively" serious or permanent should be included.  Any side effect, e.g., sterility, scarring, should be mentioned.

 

Examples:

This drug may cause an allergic reaction such as skin rashes or hives.  It can cause a rare, penicillin-like, allergic reaction that could be life-threatening.

 

You may be assigned to a group that is later shown to have more side effects or be a less effective treatment.  This information will not be known until the study data is analyzed.

 

Taking blood from a vein may cause discomfort or bruising at the site.

 

A small amount of heparin, an anti-clotting medication, is used with the temporary needle.  You may experience discomfort, bleeding, bruising or infection at the needle site.  Blood will be drawn X times from the temporary needle and then the needle will be removed at the end of the X hours.  A total of about XXccs (XX teaspoons) of blood will be drawn.

 

The interview will take approximately two hours of your time.  You may regard some of these questions as sensitive and private.  You do not have to answer any question that makes you feel uncomfortable.  Your name will not appear in any published information.  Confidentiality will be protected.

 

As part of this study you will have (kinds and numbers of x-ray or isotope procedures).  The total radiation you will receive will be (fraction) of the limit recommended by the FDA for research in humans receiving radiation.  The amount is low enough that it is very unlikely to be dangerous, although the lasting effects of small amounts of radiation in humans are unknown.  Much larger doses cause cancer and birth defects in humans.

 

If pregnant women and/or nursing mothers are to be EXCLUDED from the study, the following statement should be included:

 

If it is possible that you could be pregnant, or if you are breastfeeding, you must not    participate in this study.

 

If women of childbearing years are to be INCLUDED in a greater than minimal risk study, the following statements should be considered and if appropriate included:

 

If you are a woman and are pregnant or breastfeeding you must not participate in this study.  If you are a woman of childbearing years, a pregnancy test will be done to assure that you are not pregnant.  You must use a reliable form of contraceptive while participating in this study.  If you should become pregnant at any time during the study, you must notify your doctor.

 

6.   Benefits:  An unbiased statement should be included.  It should not be overstated or read like an advertisement.

 

Examples:

There will be no direct benefit to you from participating.  The investigators hope to learn more about X and Y, which may help treat patients like you more effectively in the future.

 

The additional tests to be done are not needed for treatment or your diagnosis.  The       information put in your medical record may be of interest to your personal physician.

Information from recent research suggests that this procedure of antibiotic administration may be more effective in eliminating your infection.  By using this new procedure you will not require an I.V. for six weeks.

 

NOTE:     MONEY PAID TO SUBJECTS OR FREE MEDICAL CARE ARE NOT CONSIDERED A BENEFIT.

 

7.   Standard Treatment Withheld Or Alternatives Available:  This section must describe the options open if the subject refuses participation.  Standard treatment withheld must be stated here.  If the only alternative is simple refusal, e.g., to throw away a questionnaire, this section may be omitted.

 


Examples:

Instead of participating in the study, you and your doctor may make the decision. Thetreatments available are drugs A, B or C.

 

If you choose not to participate in this study, standard therapy/alternative therapy/other alternative procedures will be available to you. (Describe)

 

8.   Costs And Compensation:  Make a clear statement about any additional costs to the patient. Compensation/payment is to be offered only to pay for expenses, time, or inconvenience. Payment is not for inducing people to assume any risk. The IRB encourages investigators to discuss costs with them.

 

Examples:

Those laboratory tests not directly required for your care will be provided at no cost to you.

 

If the pacemaker must be changed for any reason, a replacement unit will be provided by the sponsor at no cost to you.  However, payment for the medical care related to the implantation of the unit, such as surgery, physician services, hospitalization, medication, etc., must be made by you or your third party payer (insurance, Medicare, etc.).

 

You will be given $10.00 for each visit plus an added $5.00 whenever blood is drawn, for a total of $65.00.  You will receive an additional $15.00 for completing all the visits.

 

9.   Treatment For Research-Related Injury:  Do not forget to include the statement on treatment and compensation for harm if there is any real or foreseeable risk of physical harm.

 

Examples:

If you are injured as a result of being in this study, medical treatment will be available to you. The costs of such treatment will be paid for by XYZ Pharmaceutical Company.

 

If you perceive any harmful effects or symptoms as a result of being in this study, medical treatment will be available to you.  The cost of such treatment must be paid by you or your third party payer (insurance, Medicare, etc.).

 

10.  Confidentiality:

 

Examples:

All information collected as part of this study which can be identified with you will be kept confidential and will be released only with your written permission.

 

Only the investigator, the sponsor (XYZ Pharmaceutical Corp.) and, under certain circumstances, the U.S. Food and Drug Administration will be able to review and/or obtain data which identifies you by name.

 

11.  Questions:  Few patients are able to comprehend the study immediately.  It is important to offer a 24 hour number for the investigator in the event of delayed effects or questions.  If the investigator is at REGIONS HOSPITAL/RC part-time, include the name and number of a full-time REGIONS HOSPITAL/RC staff member who is knowledgeable about the study.  The Patient Representative statement must be used when REGIONS HOSPITAL patients are involved.

 

Example:

If you have questions, please ask them now.  If you have any additional questions later, you may reach Dr. Jones at 221-0000.

 


 

 

You must use the following statement if the subjects are patients at Regions Hospital.

 

As is the case for all patients of Regions Hospital, you have access to the Patient Representative (651-254-2372) if you have questions or concerns which have not been answered by your physician or the researcher or about your rights as a research subject.

 

12.  Voluntary Participation:

 

Example:

Participation in research is voluntary.  You have the right to refuse to participate and the right to withdraw later without affecting (your present or future treatment at the Medical Center,) (your grades,) (your employment,) (etc.).

 

13.  Copy Of Consent Form:

 

Example:

You will be given a copy of this consent form to keep.

 

14.  Signatures: 

I have had a chance to ask questions about the study including the risks of harmful effects that might occur as described in this consent form.  Based on this information, I willingly agree to participate in the study.

 

___________________________                   ______________

Signature of Subject                                           Date

 

I, the investigator, certify that to the best of my knowledge, the patient/participant/person responsible signing this consent form has had the study fully explained and clearly understands the nature, risks, and any benefits of participating in this research project.

 

___________________________                   ______________

Signature of Investigator                                     Date

 

If appropriate for the specific study:

I, as the relative/person responsible for the research subject, have had a chance to ask questions about the study including the risks of harmful effects that might occur as described in this consent form.  Based on this information, I willingly agree to allow the patient/my relative to participate in the study.

 

___________________________                   ______________

Signature of Person Responsible                        Date

 


 

 

Example Of Abbreviated Consent Form For Minimal Risk Study

 

Regions Hospital

Consent To Be A Research Subject

 

Dr. Jones is doing a study to learn more about anemia.  To do this she needs to collect a small amount of blood from healthy people and from people with anemia.

 

If you agree to participate, a trained technician will remove (        tsp.) of blood from your arm vein.

 

Having the blood drawn may be somewhat uncomfortable and may produce a bruise at the site.

 

The study may produce information of use to patients in the future, but there will be no direct benefit to you.

 

If you have any questions, please ask them now.  If you have any additional questions later, you may reach Dr. Jones at 221-0000.

 

You will be given $X.00 for each donation of blood.  The laboratory tests required for this study will be provided at no cost to you.

 

Any information collected as part of this study that can be identified with you will be kept confidential.  You will be given a copy of this consent form to keep.

 

Your participation in research is voluntary.  You have the right to refuse to participate or to later withdraw from the study without affecting (your care at this Medical Center) (your employment) (your grades).

 

I have had a chance to ask questions about the study including the risks of harmful effects that might occur as described in this consent form.  Based on this information, I willingly agree to participate in the study.  All verbal information and discussions about the study have been in a language I speak, write and read easily.

 

___________________________                   ______________

Signature of Subject                                           Date

 

I, the investigator, certify that to the best of my knowledge, the patient/participant/person responsible signing this consent form has had the study fully explained and clearly understands the nature, risks, and any benefits of participating in this research project.

 

___________________________                   ______________

Signature of Investigator                                     Date

 

If appropriate for the specific study:

I, as the relative/person responsible for the research subject, have had a chance to ask questions about the study including the risks of harmful effects that might occur as described in this consent form.  Based on this information, I willingly agree to allow the patient/my relative to participate in the study.  All verbal information and discussions about the study have been in a language I speak, write and read easily.

 

___________________________                   ______________

Signature of Person Responsible                        Date


 

 

Example Consent Form For Greater Than Minimal Risk Study

 

Regions Hospital

Consent To Be A Research Subject

 

Dr. X and Dr. Y are doing a research study to learn more about the relationship between the way the surface of the stomach looks through an endoscope, on an x-ray and in a tissue specimen.  Since you have already been scheduled to have an endoscopic examination for your care, we would like to invite you to be a subject in this study.

 

Procedures

If you agree to be in the study the following will occur:  During your endoscopy a blue dye (methylene blue) will be sprayed on the surface of your stomach, through the endoscope.  A maximum of 3 small pieces of your stomach lining (biopsies) will be taken through the endoscope.  Color photographs of your stomach lining with the blue dye on it will be taken through the endoscope. These additional procedures will extend your endoscopy by about 5 minutes.  The endoscopy ordinarily takes X minutes.

 

Risks/Discomfort

Participation in this study may mean some added risk or discomfort.  A small amount of bleeding may occur after the biopsies.  This should stop by itself in a little while.  In 1 in 1000 cases bleeding continues and may require transfusion.  Your urine might turn bluish for a day.  This is normal after use of methylene blue and there is no need for concern.

 

Benefits

There will be no benefit to you from these procedures, but physicians may learn more about the tests used to evaluate the stomach lining.

 

Alternatives To Participating

If you choose to not take part in the study, your endoscopic examination will be performed in the usual way, without the biopsies or photographs.

 

Costs

There will be no additional charges to you if you do participate in the study.

 

Research Related Injury

If you are injured as a result of being in this study, treatment will be available.  The costs of such treatment must be paid by you or your third party payer (insurance, Medicare, etc.).

 

OR

 

The costs of such treatment will be paid by the sponsor of this study.

 

Confidentiality

All information obtained in connection with the study that can be identified with you will remain confidential and will be released only with your written permission.

 

Questions:

Dr. X has talked with you about this study and has answered your questions.  If you have other questions you may call him at 221-0000.  As is the case for all patients of Regions Hospital, you have access to the Patient Representative (651-254-2372 ) if you have questions or concerns which have not been answered by your physician or the researcher or about your rights as a research subject.

 

Voluntary Participation

Participation in research is voluntary.  You may refuse to participate or you may withdraw at any time without affecting the treatment you receive at the Medical Center.

 

You will be given a copy of this consent form to keep.

 

 

I have read and understand the preceding information.  I have had an opportunity to ask questions and all my questions have been answered to my satisfaction.  I understand that by signing this form I am agreeing to participate in this study.  I may withdraw from this study at any time without affecting my present or future care at Regions Hospital (clinic).

 

                                                                                                        

Signature of patient/person responsible and          Date

relationship

 

                                                                                                       

Signature of person obtaining consent                    Date


 

Elements of Informed Consent:
Requirements and Guidelines for Consent Forms:

Informed consent is the process of communicating to the subject the purpose, risks, benefits, and voluntary nature of a specific study.

The consent form documents that the communication process took place.  The consent form must contain all of the required "elements" of informed consent.  The "sample consent form" should be used as a guide for writing a consent form.  The consent form should be written in lay terms; jargon and technical language should be avoided.  The IRB recommends that researchers write the consent forms using simple declarative sentences, avoid technical language.

Tips for completing consent form: